Related Experiment Video
Updated: Aug 11, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Disability Status and Prostate Cancer Screening Among US Men Aged 55 to 69 Years
José I Nolazco1,2, Lisa I Iezzoni3,4, Eugene C Chen5
1Department of Urology, Mass General Brigham, Harvard Medical School, Boston, Massachusetts.
JAMA Network Open
|August 10, 2026
Summary
Men with disabilities are less likely to undergo prostate-specific antigen (PSA) testing. This study highlights disparities in preventive care for men with disabilities, particularly mobility impairments, underscoring the need for targeted interventions.
Area of Science:
- Public Health
- Preventive Medicine
- Health Disparities
Background:
- Individuals with disabilities face significant inequities in accessing preventive healthcare services.
- Limited current data exists on prostate-specific antigen (PSA) testing disparities among disabled populations in the U.S.
Purpose of the Study:
- To investigate the association between disability status and self-reported PSA testing rates.
- To analyze PSA testing disparities among U.S. men aged 55 to 69 years based on disability.
Main Methods:
- Cross-sectional study utilizing 2023 Behavioral Risk Factor Surveillance System (BRFSS) data.
- Included 10,508 male respondents aged 55-69 with complete PSA testing and disability information.
- Survey-weighted logistic regression analyzed associations, controlling for covariates; multiple imputation handled missing data.
Main Results:
- 29.6% of the 5,058,866 weighted sample reported at least one disability.
- Men with disabilities had lower PSA testing rates (57.2%) compared to those without (65.1%).
- Disability was associated with reduced odds of PSA testing (AOR, 0.83), with mobility disability showing a significant association (AOR, 0.77).
Conclusions:
- Disability status is linked to lower PSA testing rates in U.S. men aged 55-69.
- Mobility disability showed the most consistent disparity in PSA testing.
- Findings suggest disability is an under-recognized factor in preventive care access, necessitating targeted interventions for equitable screening.
